Refractory Classical Hodgkin Lymphoma Presenting with Atypical Cutaneous Involvement and Diagnosis of ZZ Phenotype Alpha-1 Antitrypsin Deficiency

<table>(a) PET scan during brentuximab therapy, (b) PET scan after 2 cycles of bendamustine, (c) PET scan after 2 cycles of GCD, and (d) PET scan at conclusion of treatment with GCD. Pleurodesis inflammatory changes remained on imaging.</table>

Case Reports in Hematology

fig4

Figure 4

Figure 4: Refractory Classical Hodgkin Lymphoma Presenting with Atypical Cutaneous Involvement and Diagnosis of ZZ Phenotype Alpha-1 Antitrypsin Deficiency 

Figure 4 | Refractory Classical Hodgkin Lymphoma Presenting with Atypical Cutaneous Involvement and Diagnosis of ZZ Phenotype Alpha-1 Antitrypsin Deficiency 